img

Global Angiopoietin 2 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Angiopoietin 2 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Angiopoietin 2 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Angiopoietin 2 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Angiopoietin 2 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Angiopoietin 2 key manufacturers include Amgen Inc., AnGes MG, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., MedImmune, LLC, Regeneron Pharmaceuticals, Inc., RXi Pharmaceuticals Corporation and Silence Therapeutics Plc, etc. Amgen Inc., AnGes MG, Inc., Boehringer Ingelheim GmbH are top 3 players and held % sales share in total in 2022.
Angiopoietin 2 can be divided into Atu-111, BI-836880, LY-3127804 and MEDI-3617, etc. Atu-111 is the mainstream product in the market, accounting for % sales share globally in 2022.
Angiopoietin 2 is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Angiopoietin 2 industry development. In 2022, global % sales of Angiopoietin 2 went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Angiopoietin 2 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
Segment by Type
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Angiopoietin 2 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Angiopoietin 2, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Angiopoietin 2 industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Angiopoietin 2 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Angiopoietin 2 introduction, etc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Angiopoietin 2 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Angiopoietin 2 Market Overview
1.1 Angiopoietin 2 Product Overview
1.2 Angiopoietin 2 Market Segment by Type
1.2.1 Atu-111
1.2.2 BI-836880
1.2.3 LY-3127804
1.2.4 MEDI-3617
1.2.5 Others
1.3 Global Angiopoietin 2 Market Size by Type
1.3.1 Global Angiopoietin 2 Market Size Overview by Type (2018-2034)
1.3.2 Global Angiopoietin 2 Historic Market Size Review by Type (2018-2024)
1.3.3 Global Angiopoietin 2 Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Angiopoietin 2 Sales Breakdown by Type (2018-2024)
1.4.2 Europe Angiopoietin 2 Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Angiopoietin 2 Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Angiopoietin 2 Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Angiopoietin 2 Sales Breakdown by Type (2018-2024)
2 Global Angiopoietin 2 Market Competition by Company
2.1 Global Top Players by Angiopoietin 2 Sales (2018-2024)
2.2 Global Top Players by Angiopoietin 2 Revenue (2018-2024)
2.3 Global Top Players by Angiopoietin 2 Price (2018-2024)
2.4 Global Top Manufacturers Angiopoietin 2 Manufacturing Base Distribution, Sales Area, Product Type
2.5 Angiopoietin 2 Market Competitive Situation and Trends
2.5.1 Angiopoietin 2 Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Angiopoietin 2 Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiopoietin 2 as of 2022)
2.7 Date of Key Manufacturers Enter into Angiopoietin 2 Market
2.8 Key Manufacturers Angiopoietin 2 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Angiopoietin 2 Status and Outlook by Region
3.1 Global Angiopoietin 2 Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Angiopoietin 2 Historic Market Size by Region
3.2.1 Global Angiopoietin 2 Sales in Volume by Region (2018-2024)
3.2.2 Global Angiopoietin 2 Sales in Value by Region (2018-2024)
3.2.3 Global Angiopoietin 2 Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Angiopoietin 2 Forecasted Market Size by Region
3.3.1 Global Angiopoietin 2 Sales in Volume by Region (2024-2034)
3.3.2 Global Angiopoietin 2 Sales in Value by Region (2024-2034)
3.3.3 Global Angiopoietin 2 Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Angiopoietin 2 by Application
4.1 Angiopoietin 2 Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Angiopoietin 2 Market Size by Application
4.2.1 Global Angiopoietin 2 Market Size Overview by Application (2018-2034)
4.2.2 Global Angiopoietin 2 Historic Market Size Review by Application (2018-2024)
4.2.3 Global Angiopoietin 2 Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Angiopoietin 2 Sales Breakdown by Application (2018-2024)
4.3.2 Europe Angiopoietin 2 Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Angiopoietin 2 Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Angiopoietin 2 Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Angiopoietin 2 Sales Breakdown by Application (2018-2024)
5 North America Angiopoietin 2 by Country
5.1 North America Angiopoietin 2 Historic Market Size by Country
5.1.1 North America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Angiopoietin 2 Sales in Volume by Country (2018-2024)
5.1.3 North America Angiopoietin 2 Sales in Value by Country (2018-2024)
5.2 North America Angiopoietin 2 Forecasted Market Size by Country
5.2.1 North America Angiopoietin 2 Sales in Volume by Country (2024-2034)
5.2.2 North America Angiopoietin 2 Sales in Value by Country (2024-2034)
6 Europe Angiopoietin 2 by Country
6.1 Europe Angiopoietin 2 Historic Market Size by Country
6.1.1 Europe Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Angiopoietin 2 Sales in Volume by Country (2018-2024)
6.1.3 Europe Angiopoietin 2 Sales in Value by Country (2018-2024)
6.2 Europe Angiopoietin 2 Forecasted Market Size by Country
6.2.1 Europe Angiopoietin 2 Sales in Volume by Country (2024-2034)
6.2.2 Europe Angiopoietin 2 Sales in Value by Country (2024-2034)
7 Asia-Pacific Angiopoietin 2 by Region
7.1 Asia-Pacific Angiopoietin 2 Historic Market Size by Region
7.1.1 Asia-Pacific Angiopoietin 2 Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Angiopoietin 2 Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Angiopoietin 2 Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Angiopoietin 2 Forecasted Market Size by Region
7.2.1 Asia-Pacific Angiopoietin 2 Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Angiopoietin 2 Sales in Value by Region (2024-2034)
8 Latin America Angiopoietin 2 by Country
8.1 Latin America Angiopoietin 2 Historic Market Size by Country
8.1.1 Latin America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Angiopoietin 2 Sales in Volume by Country (2018-2024)
8.1.3 Latin America Angiopoietin 2 Sales in Value by Country (2018-2024)
8.2 Latin America Angiopoietin 2 Forecasted Market Size by Country
8.2.1 Latin America Angiopoietin 2 Sales in Volume by Country (2024-2034)
8.2.2 Latin America Angiopoietin 2 Sales in Value by Country (2024-2034)
9 Middle East and Africa Angiopoietin 2 by Country
9.1 Middle East and Africa Angiopoietin 2 Historic Market Size by Country
9.1.1 Middle East and Africa Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Angiopoietin 2 Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Angiopoietin 2 Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Angiopoietin 2 Forecasted Market Size by Country
9.2.1 Middle East and Africa Angiopoietin 2 Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Angiopoietin 2 Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Amgen Inc.
10.1.1 Amgen Inc. Company Information
10.1.2 Amgen Inc. Introduction and Business Overview
10.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amgen Inc. Angiopoietin 2 Products Offered
10.1.5 Amgen Inc. Recent Development
10.2 AnGes MG, Inc.
10.2.1 AnGes MG, Inc. Company Information
10.2.2 AnGes MG, Inc. Introduction and Business Overview
10.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AnGes MG, Inc. Angiopoietin 2 Products Offered
10.2.5 AnGes MG, Inc. Recent Development
10.3 Boehringer Ingelheim GmbH
10.3.1 Boehringer Ingelheim GmbH Company Information
10.3.2 Boehringer Ingelheim GmbH Introduction and Business Overview
10.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Products Offered
10.3.5 Boehringer Ingelheim GmbH Recent Development
10.4 Eli Lilly and Company
10.4.1 Eli Lilly and Company Company Information
10.4.2 Eli Lilly and Company Introduction and Business Overview
10.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Eli Lilly and Company Angiopoietin 2 Products Offered
10.4.5 Eli Lilly and Company Recent Development
10.5 F. Hoffmann-La Roche Ltd.
10.5.1 F. Hoffmann-La Roche Ltd. Company Information
10.5.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Products Offered
10.5.5 F. Hoffmann-La Roche Ltd. Recent Development
10.6 MedImmune, LLC
10.6.1 MedImmune, LLC Company Information
10.6.2 MedImmune, LLC Introduction and Business Overview
10.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.6.4 MedImmune, LLC Angiopoietin 2 Products Offered
10.6.5 MedImmune, LLC Recent Development
10.7 Regeneron Pharmaceuticals, Inc.
10.7.1 Regeneron Pharmaceuticals, Inc. Company Information
10.7.2 Regeneron Pharmaceuticals, Inc. Introduction and Business Overview
10.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Products Offered
10.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
10.8 RXi Pharmaceuticals Corporation
10.8.1 RXi Pharmaceuticals Corporation Company Information
10.8.2 RXi Pharmaceuticals Corporation Introduction and Business Overview
10.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Products Offered
10.8.5 RXi Pharmaceuticals Corporation Recent Development
10.9 Silence Therapeutics Plc
10.9.1 Silence Therapeutics Plc Company Information
10.9.2 Silence Therapeutics Plc Introduction and Business Overview
10.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Silence Therapeutics Plc Angiopoietin 2 Products Offered
10.9.5 Silence Therapeutics Plc Recent Development
10.10 Synergys Biotherapeutics, Inc.
10.10.1 Synergys Biotherapeutics, Inc. Company Information
10.10.2 Synergys Biotherapeutics, Inc. Introduction and Business Overview
10.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Products Offered
10.10.5 Synergys Biotherapeutics, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Angiopoietin 2 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Angiopoietin 2 Industrial Chain Analysis
11.4 Angiopoietin 2 Market Dynamics
11.4.1 Angiopoietin 2 Industry Trends
11.4.2 Angiopoietin 2 Market Drivers
11.4.3 Angiopoietin 2 Market Challenges
11.4.4 Angiopoietin 2 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Angiopoietin 2 Distributors
12.3 Angiopoietin 2 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Atu-111
Table 2. Major Company of BI-836880
Table 3. Major Company of LY-3127804
Table 4. Major Company of MEDI-3617
Table 5. Major Company of Others
Table 6. Global Angiopoietin 2 Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Angiopoietin 2 Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Angiopoietin 2 Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Angiopoietin 2 Sales by Type (2018-2024) & (US& Million)
Table 10. Global Angiopoietin 2 Market Share in Value by Type (2018-2024)
Table 11. Global Angiopoietin 2 Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Angiopoietin 2 Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Angiopoietin 2 Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Angiopoietin 2 Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Angiopoietin 2 Sales Market Share in Value by Type (2024-2034)
Table 16. Global Angiopoietin 2 Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Angiopoietin 2 Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Angiopoietin 2 Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Angiopoietin 2 Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Angiopoietin 2 Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Angiopoietin 2 Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Angiopoietin 2 Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Angiopoietin 2 Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Angiopoietin 2 Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Angiopoietin 2 Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Angiopoietin 2 Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Angiopoietin 2 Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Angiopoietin 2 Sales Share by Company (2018-2024)
Table 29. Global Angiopoietin 2 Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Angiopoietin 2 Revenue Share by Company (2018-2024)
Table 31. Global Market Angiopoietin 2 Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Angiopoietin 2 Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Angiopoietin 2 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiopoietin 2 as of 2022)
Table 35. Date of Key Manufacturers Enter into Angiopoietin 2 Market
Table 36. Key Manufacturers Angiopoietin 2 Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Angiopoietin 2 Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Angiopoietin 2 Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Angiopoietin 2 Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Angiopoietin 2 Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Angiopoietin 2 Sales Market Share in Value by Region (2018-2024)
Table 43. Global Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Angiopoietin 2 Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Angiopoietin 2 Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Angiopoietin 2 Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Angiopoietin 2 Sales Market Share in Value by Region (2024-2034)
Table 48. Global Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Angiopoietin 2 Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Angiopoietin 2 Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Angiopoietin 2 Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Angiopoietin 2 Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Angiopoietin 2 Sales Market Share in Value by Application (2018-2024)
Table 54. Global Angiopoietin 2 Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Angiopoietin 2 Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Angiopoietin 2 Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Angiopoietin 2 Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Angiopoietin 2 Sales Market Share in Value by Application (2024-2034)
Table 59. Global Angiopoietin 2 Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Angiopoietin 2 Sales by Application (2018-2024) (K Pcs)
Table 61. North America Angiopoietin 2 Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Angiopoietin 2 Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Angiopoietin 2 Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Angiopoietin 2 Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Angiopoietin 2 Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Angiopoietin 2 Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Angiopoietin 2 Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Angiopoietin 2 Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Angiopoietin 2 Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Angiopoietin 2 Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Angiopoietin 2 Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Angiopoietin 2 Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Angiopoietin 2 Sales Market Share in Value by Country (2018-2024)
Table 74. North America Angiopoietin 2 Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Angiopoietin 2 Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Angiopoietin 2 Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Angiopoietin 2 Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Angiopoietin 2 Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Angiopoietin 2 Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Angiopoietin 2 Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Angiopoietin 2 Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Angiopoietin 2 Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Angiopoietin 2 Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Angiopoietin 2 Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Angiopoietin 2 Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Angiopoietin 2 Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Angiopoietin 2 Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Angiopoietin 2 Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Angiopoietin 2 Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Angiopoietin 2 Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Angiopoietin 2 Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Angiopoietin 2 Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Angiopoietin 2 Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Angiopoietin 2 Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Angiopoietin 2 Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Angiopoietin 2 Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Angiopoietin 2 Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Angiopoietin 2 Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Angiopoietin 2 Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Angiopoietin 2 Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Angiopoietin 2 Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Angiopoietin 2 Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Angiopoietin 2 Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Angiopoietin 2 Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Angiopoietin 2 Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Angiopoietin 2 Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Angiopoietin 2 Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Angiopoietin 2 Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Angiopoietin 2 Sales Market Share in Value by Country (2024-2034)
Table 110. Amgen Inc. Company Information
Table 111. Amgen Inc. Introduction and Business Overview
Table 112. Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Amgen Inc. Angiopoietin 2 Product
Table 114. Amgen Inc. Recent Development
Table 115. AnGes MG, Inc. Company Information
Table 116. AnGes MG, Inc. Introduction and Business Overview
Table 117. AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. AnGes MG, Inc. Angiopoietin 2 Product
Table 119. AnGes MG, Inc. Recent Development
Table 120. Boehringer Ingelheim GmbH Company Information
Table 121. Boehringer Ingelheim GmbH Introduction and Business Overview
Table 122. Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Boehringer Ingelheim GmbH Angiopoietin 2 Product
Table 124. Boehringer Ingelheim GmbH Recent Development
Table 125. Eli Lilly and Company Company Information
Table 126. Eli Lilly and Company Introduction and Business Overview
Table 127. Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Eli Lilly and Company Angiopoietin 2 Product
Table 129. Eli Lilly and Company Recent Development
Table 130. F. Hoffmann-La Roche Ltd. Company Information
Table 131. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 132. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product
Table 134. F. Hoffmann-La Roche Ltd. Recent Development
Table 135. MedImmune, LLC Company Information
Table 136. MedImmune, LLC Introduction and Business Overview
Table 137. MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. MedImmune, LLC Angiopoietin 2 Product
Table 139. MedImmune, LLC Recent Development
Table 140. Regeneron Pharmaceuticals, Inc. Company Information
Table 141. Regeneron Pharmaceuticals, Inc. Introduction and Business Overview
Table 142. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product
Table 144. Regeneron Pharmaceuticals, Inc. Recent Development
Table 145. RXi Pharmaceuticals Corporation Company Information
Table 146. RXi Pharmaceuticals Corporation Introduction and Business Overview
Table 147. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. RXi Pharmaceuticals Corporation Angiopoietin 2 Product
Table 149. RXi Pharmaceuticals Corporation Recent Development
Table 150. Silence Therapeutics Plc Company Information
Table 151. Silence Therapeutics Plc Introduction and Business Overview
Table 152. Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Silence Therapeutics Plc Angiopoietin 2 Product
Table 154. Silence Therapeutics Plc Recent Development
Table 155. Synergys Biotherapeutics, Inc. Company Information
Table 156. Synergys Biotherapeutics, Inc. Introduction and Business Overview
Table 157. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product
Table 159. Synergys Biotherapeutics, Inc. Recent Development
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Angiopoietin 2 Market Trends
Table 163. Angiopoietin 2 Market Drivers
Table 164. Angiopoietin 2 Market Challenges
Table 165. Angiopoietin 2 Market Restraints
Table 166. Angiopoietin 2 Distributors List
Table 167. Angiopoietin 2 Downstream Customers
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiopoietin 2 Product Picture
Figure 2. Global Angiopoietin 2 Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Angiopoietin 2 Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Angiopoietin 2 Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Atu-111
Figure 6. Global Atu-111 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of BI-836880
Figure 8. Global BI-836880 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of LY-3127804
Figure 10. Global LY-3127804 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of MEDI-3617
Figure 12. Global MEDI-3617 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Angiopoietin 2 Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Angiopoietin 2 Sales Market Share by Type in 2022 & 2034
Figure 17. North America Angiopoietin 2 Sales Market Share in Volume by Type in 2022
Figure 18. North America Angiopoietin 2 Sales Market Share in Value by Type in 2022
Figure 19. Europe Angiopoietin 2 Sales Market Share in Volume by Type in 2022
Figure 20. Europe Angiopoietin 2 Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Angiopoietin 2 Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Angiopoietin 2 Sales Market Share in Value by Type in 2022
Figure 23. Latin America Angiopoietin 2 Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Angiopoietin 2 Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Angiopoietin 2 Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Angiopoietin 2 Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiopoietin 2 Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiopoietin 2 Revenue in 2022
Figure 29. Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Clinic
Figure 33. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Angiopoietin 2 Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Angiopoietin 2 Sales Market Share by Application in 2022 & 2034
Figure 38. North America Angiopoietin 2 Sales Market Share in Volume by Application in 2022
Figure 39. North America Angiopoietin 2 Sales Market Share in Value by Application in 2022
Figure 40. Europe Angiopoietin 2 Sales Market Share in Volume by Application in 2022
Figure 41. Europe Angiopoietin 2 Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Angiopoietin 2 Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Angiopoietin 2 Sales Market Share in Value by Application in 2022
Figure 44. Latin America Angiopoietin 2 Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Angiopoietin 2 Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Angiopoietin 2 Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Angiopoietin 2 Manufacturing Cost Structure
Figure 49. Angiopoietin 2 Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed